IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 1 filers reported holding IVERIC BIO INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,325 | -31.2% | 33,700 | -57.4% | 0.01% | +100.0% |
| Q1 2023 | $1,926 | +445.6% | 79,200 | +380.0% | 0.00% | +50.0% |
| Q4 2022 | $353 | -99.9% | 16,500 | +13.8% | 0.00% | +100.0% |
| Q3 2022 | $260,000 | -3.7% | 14,500 | -48.4% | 0.00% | 0.0% |
| Q2 2022 | $270,000 | -45.0% | 28,100 | -3.8% | 0.00% | -50.0% |
| Q1 2022 | $491,000 | -4.5% | 29,200 | -5.2% | 0.00% | 0.0% |
| Q4 2021 | $514,000 | +2.8% | 30,800 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $500,000 | +240.1% | 30,800 | +31.6% | 0.00% | +100.0% |
| Q2 2021 | $147,000 | +12.2% | 23,400 | +10.4% | 0.00% | – |
| Q1 2021 | $131,000 | -10.3% | 21,200 | 0.0% | 0.00% | -100.0% |
| Q4 2020 | $146,000 | +22.7% | 21,200 | 0.0% | 0.00% | – |
| Q3 2020 | $119,000 | -34.3% | 21,200 | -40.4% | 0.00% | -100.0% |
| Q2 2020 | $181,000 | – | 35,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |